![David Gardner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Gardner
Sales & Marketing chez
iShares Plc
Profil
David Gardner is currently the Head-EMEA Sales at iShares Plc.
Prior to this, he worked as a Director at Xilio Therapeutics, Inc. in 2021.
He also worked as an Analyst at BlackRock Advisors LLC from 2009 to 2011.
Postes actifs de David Gardner
| Sociétés | Poste | Début |
|---|---|---|
iShares Plc
 iShares Plc Investment Trusts/Mutual FundsMiscellaneous Exchange Traded Fund | Sales & Marketing | 20/10/2011 |
Anciens postes connus de David Gardner
| Sociétés | Poste | Fin |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/10/2021 |
BlackRock Advisors LLC
 BlackRock Advisors LLC Investment ManagersFinance BlackRock Advisors offers investors around the world a variety of investment products that span across asset classes, market-caps, investment styles and geographic regions. Their mandates include cash management, equity, fixed income, alternative, multi-asset and quantitative equity strategies. | Analyst-Equity | 09/09/2011 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
BlackRock Advisors LLC
BlackRock Advisors LLC Investment ManagersFinance BlackRock Advisors offers investors around the world a variety of investment products that span across asset classes, market-caps, investment styles and geographic regions. Their mandates include cash management, equity, fixed income, alternative, multi-asset and quantitative equity strategies. | Finance |
iShares Plc
iShares Plc Investment Trusts/Mutual FundsMiscellaneous Exchange Traded Fund | Miscellaneous |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
